Literature DB >> 14999161

Diagnosis and treatment of depression during pregnancy.

Lee S Cohen1, Ruta Nonacs, Adele C Viguera, Alison Reminick.   

Abstract

Pregnancy has frequently been described as a time of affective well-being. However, a growing literature suggests that women are neither "protected" against new-onset or recurrence of depression during this time. Diagnosis and effective treatment of depression during pregnancy requires a careful weighing of risk of treatment which may include psychotropic medications against the risks associated with failure to adequately manage affective distress and its potential impact of maternal and fetal well-being. Treatment options during pregnancy are reviewed in the context of developing the most appropriate risk/benefit decision for individual patients with past or current depression who either anticipate pregnancy or who become pregnant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999161     DOI: 10.1017/s1092852900009007

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  12 in total

1.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

2.  The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.

Authors:  Margaret S Chisolm; Emily P Brigham; Michelle Tuten; Eric C Strain; Hendrée E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

3.  Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects.

Authors:  Kristin J Weaver; Ian A Paul; Rick C S Lin; Kimberly L Simpson
Journal:  Anat Rec (Hoboken)       Date:  2010-11       Impact factor: 2.064

4.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

Review 5.  Depression during pregnancy.

Authors:  Deirdre Ryan; Lisa Milis; Nicholas Misri
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

6.  Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development.

Authors:  Dorota Maciag; David Coppinger; Ian A Paul
Journal:  Brain Res       Date:  2006-11-13       Impact factor: 3.252

Review 7.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

8.  Efficiency of a two-item pre-screen to reduce the burden of depression screening in pregnancy and postpartum: an IMPLICIT network study.

Authors:  Ian M Bennett; Andrew Coco; James C Coyne; Alex J Mitchell; James Nicholson; Ellen Johnson; Michael Horst; Stephen Ratcliffe
Journal:  J Am Board Fam Med       Date:  2008 Jul-Aug       Impact factor: 2.657

Review 9.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

10.  Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders.

Authors:  Nidhi Khatri; Kimberly L Simpson; Rick C S Lin; Ian A Paul
Journal:  Psychopharmacology (Berl)       Date:  2013-08-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.